TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00804700

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active teaching in synchronous listening to music while exercising
Description: Subjects will be instructed to exercise while listening to four audio tutorials that are stored on their MP-3 player. These tutorials guide the subject on how to synchronize his or her body movements to the beat of the music.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active teaching in synchronous listening to music while exercising
Description: Subjects will be instructed to exercise while listening to four audio tutorials that are stored on their MP-3 player. These tutorials guide the subject on how to synchronize his or her body movements to the beat of the music.
Study: NCT00881517

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HCMV-specific hyperimmune globulin (Cytotect®)
Description: 100U (2.0ml)/Kg i.v. every 4 weeks up to 38 weeks' gestation or HCMV-positive amniocentesis or pregnancy termination.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic solution of sodium chloride (placebo)
Description: 2.0ml/Kg i.v. every 4 weeks until 38 weeks'gestation or HCMV-positive amniocentesis or pregnancy termination
Study: NCT00778778

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cefprozil 500mg tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cefprozil 500mg tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cefprozil 500mg tablets
Study: NCT02604381

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Extract

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT05865626

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VOT with and without cash incentive
Description: Here we are interested in the remote monitoring of TB treatment, and the impact that financial motivation can have on compliance with this monitoring. the cross-over here means that participants in each intervention group will at some point receive VOT without motivation and then VOT with motivation, depending on whether they start with one or the other combination

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VOT with and without cash incentive
Description: Here we are interested in the remote monitoring of TB treatment, and the impact that financial motivation can have on compliance with this monitoring. the cross-over here means that participants in each intervention group will at some point receive VOT without motivation and then VOT with motivation, depending on whether they start with one or the other combination
Study: NCT03788174

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Apatinib (500 mg qd p.o.) until disease progression or intolerable toxicity or refused by the patients.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: POF
Description: The POF regimen consisted of a 3-hour infusion of paclitaxel (135 mg/m2) followed by oxaliplatin (85 mg/m2) and Calcium Levofolinate (200 mg/m2).Subsequently, a 46-hour infusion of fluorouracil (2400 mg/m2) was administered using an ambulatory pump, repeating the cycle every 14 days.
Study: NCT03326388

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selumetinib
Description: Selumetinib Intermittent Dosing
Study: NCT01788566

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Necitumumab
Description: Administered IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Administered IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered IV
Study: NCT01667289

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy alone
Description: Radiotherapy alone Technique: IMRT Total Dose: 50 Gy Per fraction: 2 Gy

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy alone
Description: Radiotherapy alone Technique: IMRT Total Dose: 50 Gy Per fraction: 2 Gy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation
Description: Concurrent chemoradiation~Chemotherapy:~Methotrexate 40 mg/m2 weekly X 5 Radiotherapy Technique: IMRT Total dose: 50 Gy Per Fraction: 2 Gy
Study: NCT01379183

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Erythromycin
Description: 200 mg suspension

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 200 mg suspension

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: An MR enterography procedure uses magnetic resonance imaging (MRI) technology to obtain detailed images of the small bowel.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: An MR enterography procedure uses magnetic resonance imaging (MRI) technology to obtain detailed images of the small bowel.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Barium Sulfate Solution
Description: Participants will be given a low concentration of barium sulfate solution (1350 mL) prior to the MRI procedure. Barium sulfate is a radiopaque agent. Radiopaque agents are used to help diagnose certain medical problems. Since radiopaque agents are opaque to (block) x-rays, the areas of the body in which they are localized will appear white on the x-ray film. This creates the needed distinction, or contrast, between one organ and other tissues. The contrast will help the doctor see any special conditions that may exist in that organ or part of the body.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Barium Sulfate Solution
Description: Participants will be given a low concentration of barium sulfate solution (1350 mL) prior to the MRI procedure. Barium sulfate is a radiopaque agent. Radiopaque agents are used to help diagnose certain medical problems. Since radiopaque agents are opaque to (block) x-rays, the areas of the body in which they are localized will appear white on the x-ray film. This creates the needed distinction, or contrast, between one organ and other tissues. The contrast will help the doctor see any special conditions that may exist in that organ or part of the body.
Study: NCT03744728

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Accelerate PhenoTest™ BC kit
Description: The Accelerate PhenoTest™ BC kit with the Accelerate Pheno™ System is a fully-integrated in vitro diagnostic system. It is FDA-cleared to perform ID of bacteria and yeast in less than 90 minutes and AST in less than 7 hours, on average, directly from positive blood culture

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard culture and AST of positive blood culture bottles plus the Verigene® BC-GP/GN
Study: NCT03652012

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: TMS in a non-invasive brain stimulation technique. In this study, we will use TMS to excite brain tissue in the motor cortex and measure the subsequent motor response in the hand. This 'intervention' will be the same in both cohorts, as we are interested in how this motor response to TMS may vary across two distinct cohorts.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: TMS in a non-invasive brain stimulation technique. In this study, we will use TMS to excite brain tissue in the motor cortex and measure the subsequent motor response in the hand. This 'intervention' will be the same in both cohorts, as we are interested in how this motor response to TMS may vary across two distinct cohorts.
Study: NCT02530021

Intervention type: OTHER
Intervention: Heart rate monitor
Description: One hour non-invasive ECG heart rate variability monitoring. The results will be blinded and interpreted independantly. Study results will not effect patient management.
Study: NCT03167333

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: platelet rich plasma
Description: The amount of PPR was about 4-5 cc

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyaluronic acid
Description: HA was 2.5cc
Study: NCT02867735

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LKA651
Description: Interventional

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Study: NCT03274908

Intervention type: OTHER
Intervention: regular medical treatment
Description: regular medical treatment
Study: NCT02644759

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stem Cell Transplantation
Description: Interventional radiology-mediated transplantation of purified, autologous stem cells into pancreatic artery and capillaries, and intravenous injection of autologous, immunomodulated mononuclear cells.
Study: NCT03258307

Intervention type: OTHER
Group type: OTHER
Intervention: Preoperative level
Description: Blood sample

Intervention type: OTHER
Group type: OTHER
Intervention: Preoperative level
Description: Blood sample

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative level
Description: Blood sample
Study: NCT03408197

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EasyWarm
Description: Perioperative warming with EasyWarm to prevent inadvertent hypothermia during anaesthesia

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BairHugger
Description: Perioperative warming with BairHugger to prevent inadvertent hypothermia during anaesthesia
Study: NCT03748966

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol
Description: Adults and children (age 3-17) with X-linked hypophosphatemia will be treated with calcitriol therapy without phosphate supplementation. Doses of calcitriol will be escalated and optimized in the first three months of the study. Calcitriol is an oral medication taken once a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol
Description: Adults and children (age 3-17) with X-linked hypophosphatemia will be treated with calcitriol therapy without phosphate supplementation. Doses of calcitriol will be escalated and optimized in the first three months of the study. Calcitriol is an oral medication taken once a day.
Study: NCT04337424

Intervention type: DIAGNOSTIC_TEST
Intervention: Sampling salivary
Description: Collection of 1 to 2 ml of saliva

Intervention type: DIAGNOSTIC_TEST
Intervention: Sampling salivary
Description: Collection of 1 to 2 ml of saliva

Intervention type: DIAGNOSTIC_TEST
Intervention: Sampling salivary
Description: Collection of 1 to 2 ml of saliva

Intervention type: DIAGNOSTIC_TEST
Intervention: Sampling salivary
Description: Collection of 1 to 2 ml of saliva
Study: NCT04178798

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib 100 MG Oral Capsule
Description: Patients in Arm A will receive acalabrutinib as one capsule of 100 mg orally twice daily on a continuos Schedule.
Study: NCT02631096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARB-001467
Description: An IV infusion of ARB-001467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARB-001467
Description: An IV infusion of ARB-001467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARB-001467
Description: An IV infusion of ARB-001467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARB-001467
Description: An IV infusion of ARB-001467

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: An IV infusion of placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: An IV infusion of placebo

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: An IV infusion of placebo
Study: NCT02960217

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UX007
Description: liquid for oral (PO) administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UX007
Description: liquid for oral (PO) administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: liquid safflower oil for PO administration

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: liquid safflower oil for PO administration
Study: NCT04404868

Intervention type: OTHER
Intervention: Normal clinical practice
Description: There are no experimental interventions. The procedures are in line with normal clinical practice.
Study: NCT04335617

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MMPF (Micronized purified Flavonoid-Fraction)
Description: 500mg film-coated tablet, oral route, tablets should be taken at meal times. 4-day course of 6 tablets daily, followed by 4 tablets over the next 3 days followed by 2 tablets daily, one at midday and one in the evening

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 4-day course of 6 tablets daily, followed by 4 tablets over the next 3 days followed by 2 tablets daily
Study: NCT01679496

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Food items
Description: Food items with different fatty acid composition

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food items
Description: Food items with different fatty acid composition
Study: NCT04477408

Intervention type: OTHER
Group type: OTHER
Intervention: plantar sensory exercise group
Description: plantar sensitive exercises~Plantar sensitive exercises:~30 minutes / 3 days per week / 8 weeks Walking on different 4 different textured floors and hot floor (15 minute) Trying to recognize small objects with the soles of the feet (5min) Seated work with barbed ball and balance pad (5min) Massage to the sole of the foot with different textured fabrics (5min)
Study: NCT05035758

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation
Description: In the beginning, the patients from group B will receive an introductory lecture about transcendental meditation (TM) which includes general information, the procedure itself and other techniques of relaxation and personal development.~In this first session the method is learned by practice, in the following 3 meetings additional instructions are given about the correct practice of the TM technique; TM is practiced twice a day for 20 minutes. The method is easy to learn and effortless. To guarantee the right performance of TM by the patients, there will be two group meetings per week and one individual personal meeting with the TM teacher.After discharge from the rehabilitation program (after 4 weeks) there will be meetings offered according to the patients need. This will then be arranged individually.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga
Description: In addition to the standard rehabilitation exercise training, the patients in this group will receive a 20-minute workshop where they learn how to do the yoga exercise. The initial yoga workshop will be held by Dr. Gilda Wüst who is a yoga expert with a lot of experience based in St. Radegund.~After this, yoga sessions will be included (additionally to the regular/standard exercise) into their daily timetable. Two yoga sessions will be done every day, one in the morning (6:30-6:50) and one in the evening (16:30-16:50) and will last for about 20 minutes.
Study: NCT00660192

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botox
Description: subjects randomized to receive Botox with have a series of injections of onobotulinumtoxinA totalling 200 to 300 units. Botox is prepared b adding 1cc of preservative free saline in 100 unit vial. Final dose is determined by bod and neck size.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: subjects randomized to receive Placebo will have a series of injections of saline solution totalling 2cc's to 3cc's injected into the scalp in a halo pattern; and into affected neck muscles.
Study: NCT02866058

Intervention type: PROCEDURE
Intervention: Cesarean Section
Study: NCT01775774

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells
Description: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells will be administered intravenously.
Study: NCT02787395

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: shoulder dislocation self reduction
Description: shoulder dislocation self reduction using one of three methods in the study

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: shoulder dislocation self reduction
Description: shoulder dislocation self reduction using one of three methods in the study

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: shoulder dislocation self reduction
Description: shoulder dislocation self reduction using one of three methods in the study
Study: NCT00271375

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caring For You, Caring For Me
Description: 5-week Education and Support Program for Caregivers of older adults.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Caring for you, caring for me + social worker
Description: 5-week Education and Support Program for Caregivers of older adults.+ augmentation with social worker

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Control group usual care
Study: NCT02714192

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise stress test (BCTT)
Description: Participants are assessed for exercise tolerance using a treadmill with gradually increasing angle to increase workload. Stress test is stopped when there is symptom exacerbation or when participant experiences voluntary exhaustion.
Study: NCT04559854

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful After Cancer
Description: The intervention includes eight weekly sessions (1.5-2 hours each), plus participant educational materials and audio recorded meditations, and is delivered to women in their homes via group videoconference led by a trained facilitator. Participants are asked to complete activities and mindfulness practice between sessions.
Study: NCT00240058

Intervention type: DRUG
Group type: OTHER
Intervention: Regional phenylephrine arterial infusion, Nitric Oxide Clamp
Study: NCT01577017

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Women in group L will be assigned with Letrozole on night at day 5 to day 9 of the cycle
Study: NCT02483806

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PEEP
Description: After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position. Measure ABGA and cardiac indices for the baseline value. Apply each PEEP (0, 5, 10 cmH2O) serially at the random order. 6 sequences (0-\>5-\>10, 0-\>10-\>5, 5-\>10-\>0, 5-\>0-\>10, 10-\>5-\>0, 10-\>0-\>5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study. Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PEEP
Description: After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position. Measure ABGA and cardiac indices for the baseline value. Apply each PEEP (0, 5, 10 cmH2O) serially at the random order. 6 sequences (0-\>5-\>10, 0-\>10-\>5, 5-\>10-\>0, 5-\>0-\>10, 10-\>5-\>0, 10-\>0-\>5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study. Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PEEP
Description: After induction of anesthesia, including insertion of TEE probe, change position from supine to lateral position. Measure ABGA and cardiac indices for the baseline value. Apply each PEEP (0, 5, 10 cmH2O) serially at the random order. 6 sequences (0-\>5-\>10, 0-\>10-\>5, 5-\>10-\>0, 5-\>0-\>10, 10-\>5-\>0, 10-\>0-\>5) are equally applied to 6 patients (total 6x6=36 patients) who agreed to this study. Measure ABGA and cardiac indices after 20 min at each step of peep apply(3 times).
Study: NCT04369313

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: delayed cord clamping
Description: umbilical cord clamping more than 30 seconds after birth

Intervention type: PROCEDURE
Group type: OTHER
Intervention: early cord clamping
Description: umbilical cord clamping within 15 seconds after birth
Study: NCT00292942

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Artesunate
Description: Three doses of Intravenous Artesunate drug at 2, 4, or 8 mg/kg in diluent Phosphate Buffer (0.3 M, pH 8.1)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Artesunate
Description: Three doses of Intravenous Artesunate drug at 2, 4, or 8 mg/kg in diluent Phosphate Buffer (0.3 M, pH 8.1)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Artesunate
Description: Three doses of Intravenous Artesunate drug at 2, 4, or 8 mg/kg in diluent Phosphate Buffer (0.3 M, pH 8.1)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Mannitol (200 mg/vial) diluted in Phosphate Buffer and given IV in equivalent volume by subject's weight.
Study: NCT04468581

Intervention type: BEHAVIORAL
Intervention: Use of mobile application
Description: Use of the TraceTogether mobile application during the COVID-19 period
Study: NCT05464797

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulp therapy
Description: partial or complete removal of inflamed pulp tissue
Study: NCT02843269

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Multi-component lifestyle intervention
Description: The exact same intervention was given to the three Stepped-wedge groups - but each of the three groups were started up three months apart. The waiting groups served as control groups. Thus, the intervention were for all three groups a multi-component intervention consisting of Intelligent Physical Exercise training (IPET), Dietary Advice and Weight loss (DAW) and Cognitive Behavioral Therapy (CBT)
Study: NCT05464797

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulp therapy
Description: partial or complete removal of inflamed pulp tissue

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cytokines level in pulpal blood.
Description: Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Cytokines level in pulpal blood.
Description: Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cytokines level in pulpal blood.
Description: Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cytokines level in pulpal blood.
Description: Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.
Study: NCT05464797

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cytokines level in pulpal blood.
Description: Measuring the concentration of IL-8 and MMP-9 in the dental pulp during inflammation.